ZNF597
gene geneOn this page
Also known as FLJ33071HIT-4
Summary
ZNF597 (zinc finger protein 597, HGNC:26573) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 597 (Q96LX8). May be involved in transcriptional regulation.
This gene encodes a protein with multiple zinc finger domains. Loss of the related gene in rodents results in defects in neural development and embryonic lethality in mutant homozygotes. This gene is adjacent to a differentially methylated region (DMR) and is imprinted and maternally expressed.
Source: NCBI Gene 146434 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 62 total
- MANE Select transcript:
NM_152457
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26573 |
| Approved symbol | ZNF597 |
| Name | zinc finger protein 597 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ33071, HIT-4 |
| Ensembl gene | ENSG00000167981 |
| Ensembl biotype | protein_coding |
| OMIM | 614685 |
| Entrez | 146434 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000301744
RefSeq mRNA: 1 — MANE Select: NM_152457
NM_152457
CCDS: CCDS10505
Canonical transcript exons
ENST00000301744 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001118946 | 3443121 | 3443206 |
| ENSE00001118947 | 3440807 | 3440933 |
| ENSE00001118948 | 3432414 | 3437538 |
| ENSE00001118949 | 3443360 | 3443504 |
Expression profiles
Bgee: expression breadth ubiquitous, 178 present calls, max score 95.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9259 / max 75.2509, expressed in 1503 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 156031 | 3.8142 | 1498 |
| 156032 | 0.1117 | 36 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 95.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.69 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.88 | gold quality |
| oviduct epithelium | UBERON:0004804 | 76.30 | gold quality |
| oocyte | CL:0000023 | 74.90 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.81 | silver quality |
| buccal mucosa cell | CL:0002336 | 71.66 | gold quality |
| visceral pleura | UBERON:0002401 | 71.34 | gold quality |
| parietal pleura | UBERON:0002400 | 71.20 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 70.70 | silver quality |
| granulocyte | CL:0000094 | 70.38 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.22 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 69.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.90 | gold quality |
| cortical plate | UBERON:0005343 | 69.68 | gold quality |
| adrenal tissue | UBERON:0018303 | 69.28 | gold quality |
| ventricular zone | UBERON:0003053 | 68.84 | gold quality |
| leukocyte | CL:0000738 | 68.79 | gold quality |
| monocyte | CL:0000576 | 68.42 | gold quality |
| calcaneal tendon | UBERON:0003701 | 68.41 | gold quality |
| cartilage tissue | UBERON:0002418 | 67.35 | silver quality |
| gall bladder | UBERON:0002110 | 66.96 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.88 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 66.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.73 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.59 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 66.48 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 66.48 | gold quality |
| embryo | UBERON:0000922 | 66.43 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.43 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.94 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
153 targeting ZNF597, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | prdm2a | ENSDARG00000090721 |
| mus_musculus | Zfp597 | ENSMUSG00000039789 |
| rattus_norvegicus | Zfp597 | ENSRNOG00000088895 |
| drosophila_melanogaster | CG12769 | FBGN0033252 |
| caenorhabditis_elegans | WBGENE00001223 | |
| caenorhabditis_elegans | WBGENE00017406 | |
| caenorhabditis_elegans | WBGENE00019960 |
Paralogs (7): ZNF423 (ENSG00000102935), ZNF211 (ENSG00000121417), ZNF462 (ENSG00000148143), ZBTB39 (ENSG00000166860), ZNF445 (ENSG00000185219), ZNF786 (ENSG00000197362), ZNF521 (ENSG00000198795)
Protein
Protein identifiers
Zinc finger protein 597 — Q96LX8 (reviewed: Q96LX8)
All UniProt accessions (1): Q96LX8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Induction. Imprinted. Promoter methylation of the paternal allele may restrict expression to the maternal allele in leukocytes.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_689670* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (11 total): zinc finger region 7, chain 1, domain 1, sequence variant 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LX8-F1 | 48.97 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 300
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 92 (showing top):
GGAANCGGAANY_UNKNOWN, PPAR_DR1_Q2, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, WARTERS_IR_RESPONSE_5GY, GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, MIR4262, MIR548P, MIR3121_3P, MIR106B_5P, MIR20A_5P, MIR181A_5P_MIR181B_5P
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
606 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF597 | NAA60 | Q9H7X0 | 723 |
| ZNF597 | ADNP | Q9H2P0 | 608 |
| ZNF597 | ZDBF2 | Q9HCK1 | 587 |
| ZNF597 | FAM50B | Q9Y247 | 507 |
| ZNF597 | AASDHPPT | Q9NRN7 | 481 |
| ZNF597 | MEST | Q5EB52 | 447 |
| ZNF597 | USB1 | Q9BQ65 | 433 |
| ZNF597 | GNAS | Q5JWF2 | 422 |
| ZNF597 | MCTS2 | A0A3B3IRV3 | 398 |
| ZNF597 | HDGF | P51858 | 398 |
| ZNF597 | NAP1L5 | Q96NT1 | 381 |
| ZNF597 | YBX1 | P16990 | 377 |
| ZNF597 | ZC3H12C | Q9C0D7 | 370 |
| ZNF597 | CCDC185 | Q8N715 | 360 |
| ZNF597 | SNRPN | P14648 | 353 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF597 | TASOR2 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF597 | SYT17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF597 | IRAK4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF597 | CIB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CASP6 | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DMWD | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMNA | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAN | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OPTN | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF40A | ZNF597 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF597 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF597 | HCFC1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (44): ZNF597 (Two-hybrid), SMC6 (Affinity Capture-MS), NSMCE2 (Affinity Capture-MS), MPHOSPH8 (Affinity Capture-MS), NDNL2 (Affinity Capture-MS), SMC5 (Affinity Capture-MS), FAM208B (Affinity Capture-MS), NSMCE1 (Affinity Capture-MS), PPHLN1 (Affinity Capture-MS), NSMCE4A (Affinity Capture-MS), MPHOSPH8 (Affinity Capture-MS), SMC5 (Affinity Capture-MS), NSMCE2 (Affinity Capture-MS), FAM208B (Affinity Capture-MS), SMC6 (Affinity Capture-MS)
ESM2 similar proteins: A0JPL0, A1KXM5, A3CEM4, A6NK53, A7KBS4, A7MBI1, A8K554, A8MT65, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E7ETH6, E9Q8G5, F4KIH4, G3X9G7, O14628, P0CH99, P0CI00, P18853, Q32L17, Q3MJ40, Q3URS2, Q49AA0, Q4V8E9, Q5EBM4, Q5FWF6, Q5RE50, Q5REN4, Q6V9R5, Q6ZN11, Q6ZN79, Q755V9, Q80VJ6, Q86TJ5, Q8BGV5, Q8N535, Q8N720, Q8N859, Q8NC26
Diamond homologs: O15391, P08045, P18712, P18731, P18732, P18747, P25490, P38621, Q00899, Q19A41, Q3TTC2, Q5EBL2, Q62255, Q86T29, Q86UQ0, Q8BI66, Q8BIQ3, Q8BX22, Q8CJ78, Q8ST83, Q8TBZ5, Q8TF50, Q96LX8, Q99PV8, Q9BXA9, Q9ER74, Q9H165, Q9H4T2, Q9NSC2, Q9QYE3, Q9UJQ4, Q9VHJ6, O15090, P98182, Q6NX45, Q8CF60, Q8K083, Q9NX65, Q9UL36, Q8N988
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
62 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 4 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
531 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3440802:CTTA:C | donor_loss | 1.0000 |
| 16:3440804:TACC:T | donor_loss | 1.0000 |
| 16:3440805:A:AC | donor_gain | 1.0000 |
| 16:3440805:AC:A | donor_gain | 1.0000 |
| 16:3440805:ACCCA:A | donor_loss | 1.0000 |
| 16:3440806:C:CC | donor_gain | 1.0000 |
| 16:3440806:CC:C | donor_gain | 1.0000 |
| 16:3440806:CCCAT:C | donor_gain | 1.0000 |
| 16:3440929:GGTCC:G | acceptor_gain | 1.0000 |
| 16:3440931:TCC:T | acceptor_gain | 1.0000 |
| 16:3440932:CC:C | acceptor_gain | 1.0000 |
| 16:3440932:CCC:C | acceptor_gain | 1.0000 |
| 16:3440933:CC:C | acceptor_gain | 1.0000 |
| 16:3440933:CCT:C | acceptor_loss | 1.0000 |
| 16:3440934:C:A | acceptor_loss | 1.0000 |
| 16:3440934:C:CC | acceptor_gain | 1.0000 |
| 16:3440935:T:G | acceptor_loss | 1.0000 |
| 16:3443116:CTCA:C | donor_loss | 1.0000 |
| 16:3443202:CAAAG:C | acceptor_gain | 1.0000 |
| 16:3443203:AAAG:A | acceptor_gain | 1.0000 |
| 16:3443204:AAG:A | acceptor_gain | 1.0000 |
| 16:3443205:AG:A | acceptor_gain | 1.0000 |
| 16:3443206:GCTG:G | acceptor_loss | 1.0000 |
| 16:3443207:C:CC | acceptor_gain | 1.0000 |
| 16:3443208:T:C | acceptor_loss | 1.0000 |
| 16:3443354:ACTT:A | donor_loss | 1.0000 |
| 16:3443355:CTTA:C | donor_loss | 1.0000 |
| 16:3443358:A:AC | donor_gain | 1.0000 |
| 16:3443359:C:CC | donor_gain | 1.0000 |
| 16:3443359:C:CG | donor_loss | 1.0000 |
AlphaMissense
2844 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3437036:A:C | F221L | 1.000 |
| 16:3437036:A:T | F221L | 1.000 |
| 16:3437038:A:G | F221L | 1.000 |
| 16:3436952:A:C | F249L | 0.999 |
| 16:3436952:A:T | F249L | 0.999 |
| 16:3436954:A:G | F249L | 0.999 |
| 16:3437013:C:G | R229P | 0.999 |
| 16:3437019:A:G | L227P | 0.999 |
| 16:3437037:A:G | F221S | 0.999 |
| 16:3437081:A:C | H206Q | 0.999 |
| 16:3437081:A:T | H206Q | 0.999 |
| 16:3437087:T:A | R204S | 0.999 |
| 16:3437087:T:G | R204S | 0.999 |
| 16:3437095:G:C | H202D | 0.999 |
| 16:3437103:A:G | L199P | 0.999 |
| 16:3437120:G:C | F193L | 0.999 |
| 16:3437120:G:T | F193L | 0.999 |
| 16:3437122:A:G | F193L | 0.999 |
| 16:3437179:G:C | H174D | 0.999 |
| 16:3437179:G:T | H174N | 0.999 |
| 16:3437204:G:C | F165L | 0.999 |
| 16:3437204:G:T | F165L | 0.999 |
| 16:3437206:A:G | F165L | 0.999 |
| 16:3436997:G:C | H234Q | 0.998 |
| 16:3436997:G:T | H234Q | 0.998 |
| 16:3437009:G:C | H230Q | 0.998 |
| 16:3437009:G:T | H230Q | 0.998 |
| 16:3437011:G:C | H230D | 0.998 |
| 16:3437011:G:T | H230N | 0.998 |
| 16:3437031:T:G | Q223P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000055627 (16:3443745 A>C), RS1000111807 (16:3444239 G>T), RS1000163608 (16:3440006 G>A,C), RS1000305342 (16:3440253 C>G), RS1000516334 (16:3441015 A>C), RS1000545509 (16:3441834 G>A,C), RS1000588466 (16:3441171 G>A,C), RS1000705420 (16:3438163 T>G), RS1001013482 (16:3437857 G>A), RS1001286985 (16:3444483 T>C), RS1001417976 (16:3440636 A>G), RS1001469987 (16:3440506 C>G,T), RS1001697270 (16:3444257 A>C), RS1001907957 (16:3431921 G>A), RS1001944160 (16:3435404 G>A)
Disease associations
OMIM: gene MIM:614685 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases methylation, increases expression | 2 |
| Cisplatin | affects expression, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| terbufos | increases methylation | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects cotreatment, decreases expression, increases abundance | 1 |
| Parathion | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.